Moderna, Merck’s cancer vaccine breakthrough could open new avenue of treatment
Personalized cancer vaccines train the immune system to specifically target mutations found only on a person’s tumor
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.theglobeandmail.com — the content belongs to The Globe and Mail.
